Telogen Effluvium: A Review
January 2015
in “Journal of Clinical and Diagnostic Research”
TLDR Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.
The 2015 review article on Telogen Effluvium (TE) describes it as a common, non-scarring form of hair loss that usually occurs 3 months after a triggering event and lasts about 6 months, though it can persist longer in chronic cases. TE is characterized by a premature shift of hair follicles from the growth phase to the resting phase, leading to increased shedding. Diagnosis involves ruling out other causes through history, blood tests, and occasionally scalp biopsy. There are no specific FDA-approved treatments for TE, but addressing underlying causes is key, and hair regrowth is expected within 3-6 months after eliminating the trigger. Iron supplementation and a balanced diet may be beneficial, but the effectiveness of vitamins and other treatments like minoxidil is not well-established. Counseling patients on the natural progression of TE is considered the best approach.
View this study on jcdr.net →
Cited in this study
research Diffuse hair loss: Its triggers and management
To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.
research Hair evaluation methods: Merits and demerits
Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.
research Diffuse hair loss in an adult female: Approach to diagnosis and management
To manage hair loss in adult women, find the cause and treat it accordingly.
research Female pattern hair loss: current treatment concepts.
Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.
research The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.
research Decreased Serum Ferritin is Associated With Alopecia in Women
Low iron levels may be linked to some types of hair loss in women.
research Approach to the adult female patient with diffuse nonscarring alopecia
The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.
research There is no clear association between low serum ferritin and chronic diffuse telogen hair loss
Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.
research Telogen effluvium
Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.
research Shedding: How to manage a common cause of hair loss
Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.
research Study of diffuse alopecia in females.
Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.
research The Biology of Hair Follicles
Hair follicle biology advancements may lead to better hair growth disorder treatments.
research Diffuse hair loss
Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.
research CHRONIC TELOGEN EFFLUVIUM
Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.